imatinib has been researched along with Lung Neoplasms in 2 studies
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bistrović, A | 1 |
| Krstulović, L | 1 |
| Harej, A | 1 |
| Grbčić, P | 1 |
| Sedić, M | 1 |
| Koštrun, S | 1 |
| Pavelić, SK | 1 |
| Bajić, M | 1 |
| Raić-Malić, S | 1 |
| Klaeger, S | 1 |
| Heinzlmeir, S | 1 |
| Wilhelm, M | 1 |
| Polzer, H | 1 |
| Vick, B | 1 |
| Koenig, PA | 1 |
| Reinecke, M | 1 |
| Ruprecht, B | 1 |
| Petzoldt, S | 1 |
| Meng, C | 1 |
| Zecha, J | 1 |
| Reiter, K | 1 |
| Qiao, H | 1 |
| Helm, D | 1 |
| Koch, H | 1 |
| Schoof, M | 1 |
| Canevari, G | 1 |
| Casale, E | 1 |
| Depaolini, SR | 1 |
| Feuchtinger, A | 1 |
| Wu, Z | 1 |
| Schmidt, T | 1 |
| Rueckert, L | 1 |
| Becker, W | 1 |
| Huenges, J | 1 |
| Garz, AK | 1 |
| Gohlke, BO | 1 |
| Zolg, DP | 1 |
| Kayser, G | 1 |
| Vooder, T | 1 |
| Preissner, R | 1 |
| Hahne, H | 1 |
| Tõnisson, N | 1 |
| Kramer, K | 1 |
| Götze, K | 1 |
| Bassermann, F | 1 |
| Schlegl, J | 1 |
| Ehrlich, HC | 1 |
| Aiche, S | 1 |
| Walch, A | 1 |
| Greif, PA | 1 |
| Schneider, S | 1 |
| Felder, ER | 1 |
| Ruland, J | 1 |
| Médard, G | 1 |
| Jeremias, I | 1 |
| Spiekermann, K | 1 |
| Kuster, B | 1 |
2 other studies available for imatinib and Lung Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
Topics: Amidines; Antineoplastic Agents; Apoptosis; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Pro | 2018 |
The target landscape of clinical kinase drugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinas | 2017 |